Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 08, 2026 15:18 ET | Source: MEDVi

MedVi Examined (URGENT REPORT 2026) Is It Legit? Benefits, Safety, Complaints, and Customer Feedback

Find out more about MEDVi and how it works exactly! New York City, NY, Feb. 08, 2026 (GLOBE NEWSWIRE) -- Weight management has long been a challenge in the United States and rising obesity...
January 09, 2026 22:28 ET | Source: MEDVI

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026.
January 07, 2026 04:29 ET | Source: MEDVi

Is MEDVi a Trusted GLP-1 Supplier for 2026? What to Know Before Choosing a Telehealth Weight Loss Platform

New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- As demand for GLP-1 weight loss medications continues to rise in 2026, many consumers are actively searching for a reliable GLP-1 supplier...
December 27, 2025 13:40 ET | Source: MEDVi

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program?

New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Intro As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded...
October 15, 2025 15:57 ET | Source: MEDVi

MEDVi Unveiled: How the Doctor-Led MEDVi GLP-1 Program Is Democratizing Weight Loss with Compounded Semaglutide & Tirzepatide

New York City, NY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- What Is MEDVi? – Inside the Doctor-Led GLP-1 Program Revolutionizing Modern Weight Management In an era where effective weight loss solutions...